台股 » 個股 » 智擎 » 籌碼相關 » 券商分點績效 » 券商分點個股進出

智擎

(4162)
可現股當沖
  • 股價
    90.3
  • 漲跌
    ▲0.4
  • 漲幅
    +0.44%
  • 成交量
    308
  • 產業
    上櫃 生技醫療類股
  • 310人加入追蹤

    立即追蹤

  • 本地時間:13:30(已收盤)

     
智擎 (4162)籌碼相關-中國信託-永康 券商分點個股進出
券商分點績效/獲利分析

透過統計各券商分點在長期買賣某個股的操作績效,來找出真正獲利的贏家所在券商分點,進而追蹤此贏家所操作的股票與軌跡。

Created with Highstock 1.3.7Zoom券商分點個股進出嗨投資 histock.tw06/2207/0607/2208/0208/1608/3009/1409/2810/1210/2611/0811/2212/0612/2001/0401/1802/0802/2203/0805/1805/2803/2004/0104/1404/2405/06708090100110Jul '24Sep '24Nov '24Jan '25Mar '25May '2560d90dAll

中國信託-永康 券商分點個股進出

日期買進張數買進均價賣出張數賣出均價收盤價買賣超60日均量成交佔比 大量交易提示
2025/05/2300.00393.5092.40-31,120-0.27%
2025/05/2200.00192.6092.50-11,143-0.09%
2025/05/21692.3000.0092.2061,1740.51%
2025/05/20192.70392.6392.40-21,182-0.17%
2025/05/19391.00392.7391.4001,1890.00%
2025/05/1500.00791.4490.90-71,230-0.57%
2025/05/1400.00090.4091.6001,2580.00%
2025/05/131291.6000.0089.80121,2660.95%
2025/05/12691.05091.0090.6061,2980.46%
2025/05/08589.7400.0089.6051,4150.35%
2025/05/07587.20587.4087.7001,4730.00%
2025/05/06686.82687.7087.7001,6570.00%
2025/05/0200.00390.4089.70-31,776-0.17%
2025/04/30390.7000.0089.2031,7960.17%
2025/04/29291.30190.9091.0011,7910.06%
2025/04/28189.30391.0790.50-21,790-0.11%
2025/04/2100.00187.3085.80-11,775-0.06%
2025/04/15788.701088.9089.20-31,828-0.16%
2025/04/14685.20785.1785.10-11,833-0.05%
2025/04/113183.897081.8584.00-391,842-2.12%
2025/04/093478.963.377.4076.5030.71,8441.66%
2025/04/081481.391084.3084.6041,8010.22%
2025/04/0100.00298.2097.30-21,773-0.11%
2025/03/31597.0000.0096.2051,7710.28%
2025/03/281102.0000.00100.5011,7520.06%
2025/03/260.3105.502104.50104.50-1.71,723-0.10%
2025/03/2500.005104.50104.50-51,719-0.29%
2025/03/1700.000.3105.00105.00-0.31,714-0.02%
2025/03/1300.000.1107.00103.50-0.11,707-0.01%
2025/03/1200.001107.00107.00-11,695-0.06%
2025/03/1115.1105.8900.00107.0015.11,6970.89%
2025/03/101107.0000.00107.0011,6860.06%
2025/03/0713.1109.2900.00107.5013.11,6650.79%
2025/03/0500.003115.00115.50-31,645-0.18%
2025/03/040.2114.5000.00114.500.21,6340.01%
2025/03/031113.004113.75112.50-31,620-0.19%
2025/02/2700.000.2112.50109.00-0.21,568-0.01%
2025/02/261117.5010115.40115.50-91,553-0.58%
2025/02/248113.883.4114.79115.004.61,4310.32%
2025/02/210.6113.0000.00113.000.61,4120.04%
2025/02/202111.0000.00110.0021,3890.14%
2025/02/182110.500.2109.00110.001.91,4010.13%
2025/02/1700.001114.00112.50-11,397-0.07%
2025/02/1400.001111.00111.50-11,408-0.07%
2025/02/121.2111.390.2113.00112.0011,4080.07%
2025/02/113.2113.7800.00109.003.21,3920.23%
2025/02/104119.132.2119.40118.501.91,3370.14%
2025/02/077.2119.278119.06120.50-0.91,351-0.06%
2025/02/063121.8311.1118.64119.00-8.11,329-0.61%
2025/02/050.1112.5039.1109.65113.00-391,194-3.26%
2025/02/044100.806103.92103.00-21,201-0.17%
2025/01/2000.00292.5093.60-21,279-0.16%
2025/01/1700.00395.0093.20-31,364-0.22%
2025/01/16594.4000.0095.1051,3860.36%
2025/01/15394.2000.0093.1031,3800.22%
2025/01/13196.8000.0096.3011,3700.07%
2024/12/2600.00293.2092.50-21,225-0.16%
2024/12/19187.4000.0087.4011,2100.08%
2024/12/13188.9000.0088.8011,2090.08%
2024/12/12190.0000.0090.2011,1990.08%
2024/12/11191.1000.0090.6011,1930.08%
2024/12/1000.00192.2092.10-11,188-0.08%
2024/12/0900.00393.0392.50-31,184-0.25%
2024/12/06193.6000.0093.3011,1800.08%
2024/12/05194.90494.9894.60-31,170-0.26%
2024/12/03395.3000.0094.4031,1610.26%
2024/12/02395.5300.0094.4031,1580.26%
2024/11/2700.001296.0094.10-121,095-1.10%
2024/11/20396.0000.0096.5031,0180.29%
2024/11/1500.00499.9099.90-4989-0.40%
2024/11/134106.0000.00106.5049460.42%
2024/11/081101.0000.00103.0018730.11%
2024/11/062103.501101.50102.5018260.12%
2024/11/052106.5011107.91106.00-9782-1.15%
2024/11/041104.001105.00100.0007580.00%
2024/11/015106.804107.00105.0017300.14%
2024/10/291101.002.2101.86100.50-1.2604-0.19%
2024/10/2800.001102.00102.00-1576-0.17%
2024/10/2510.298.980.998.0097.409.35131.81%
2024/10/24199.00897.5098.30-7494-1.42%
2024/10/1600.00089.9089.4004760.00%
2024/10/0800.000.191.6091.10-0.1507-0.02%
2024/08/2700.00186.7086.50-1734-0.14%
2024/08/14184.5000.0083.6017550.13%
2024/08/13284.2500.0084.4027720.26%
2024/08/08185.0000.0085.4017990.13%
2024/08/0600.00480.8080.80-4783-0.51%
2024/08/052.186.9000.0083.002.17640.27%
2024/08/0100.000.294.0094.50-0.2736-0.03%
2024/07/30192.00192.9093.6007360.00%
2024/07/2600.00195.6097.60-1729-0.14%
2024/07/19196.0000.0094.2017080.14%
2024/07/18199.5000.0099.4016760.15%
2024/07/1700.00297.8098.20-2658-0.30%
2024/07/15199.0000.0098.4016630.15%
2024/07/11196.0000.0095.2016500.15%
2024/07/1000.00197.4096.60-1658-0.15%
2024/07/0300.00197.8096.70-1628-0.16%
2024/07/011100.00798.53101.00-6610-0.98%
2024/06/2600.000.296.9797.60-0.2576-0.03%
2024/06/1700.000.496.0095.50-0.4644-0.06%
2024/06/1300.00195.6096.90-1651-0.15%
2024/06/12194.20294.7594.80-1638-0.16%
2024/06/11194.2000.0095.4016360.16%
2024/06/0700.00193.8094.50-1644-0.16%
2024/06/05190.8000.0092.9016320.16%
2024/06/03190.7000.0090.7016930.14%
〈焦點股〉智擎胰腺癌新藥展望正向 股價帶量衝高Anue鉅亨-2025/03/03
智擎胰腺癌新藥2024淨銷售額達標 5000萬美元授權金將入袋Anue鉅亨-2025/02/05
智擎 相關文章